The goal of this observational study is to assess the values of Central Sensitization Inventory in women in a gynecology outpatient clinic. The main question it aims to answer is: Is there a relationship between outcomes of Central Sensitization Inventory and symptoms of pelvic floor dysfunctions reported by the patients? Participants will complete questionnaires: Central Sensitization Inventory and questionnaires assessing pelvic floor dysfunctions and their impact on quality of life (PFDI-20, PFIQ-7, PISQ-12).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Central Sensitization Inventory (CSI)
Timeframe: baseline measurement
Polish version of the Pelvic Floor Distress Inventory (PFDI-20)
Timeframe: baseline measurement
Pelvic Organ Prolapse Quantification (POP-Q) system
Timeframe: baseline measurement
Polish version of the Pelvic Floor Impact Questionnaire short form 7 (PFIQ-7)
Timeframe: baseline measurement
Polish version of the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire (PISQ-12)
Timeframe: baseline measurement